Literature DB >> 213044

Recovery of a Sendai virus variant with temperature-sensitive hemolytic activity from persistently infected cells from mouse brain.

A R Collins, T D Flanagan.   

Abstract

A persistently infected cell line designated MB/Senas was established by cultivation of mouse brain cells from four-day-old C3H mice infected intracerebrally at birth with 10(6) PFU of Sendai virus, strain 52. After 5 passages, 0.16 per cent of Sendai52 antiserum (containing two 50 per cent plaque reducing doses/ml of serum) was introduced into the culture medium. The addition of antiserum was accompanied by a rise in cell-associated viral antigen from a level of 5 per cent antigen positive cells to 100 per cent demonstrable by both intracellular and membrane immunofluorescence. A variant of Sendai52 virus, designated Sendaias, was recovered from MB/Senas by inoculation of supernatant medium into chick embryos. Infection of chick embryos at 37 degrees C was abortive. Fifty per cent or less of chick embryos infected at dilutions 10(-1) to 10(-9) yielded detectable virus. Hemagglutination (HA) was weak but could be improved by trypsinization of allantoic fluids. Neuraminidase (NA) activity was barely detectable. Hemolysis (HE) was absent. Propagation of Sendaias virus at 33 degrees C showed no change from weak HA and NA activities but HE activity was now apparent which was temperature sensitive. Mortality of infected chick embryos increased to 100 per cent. HE activity and lethality for chick embryos was thermolabile at 45 degrees C.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 213044     DOI: 10.1007/bf01315401

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  15 in total

1.  A temperature-sensitive mutant of Sendai virus with an altered hemagglutinin-neuraminidase polypeptide: consequences for virus assembly and cytopathology.

Authors:  A Portner; R A Scroggs; P S Marx; D W Kingsbury
Journal:  Virology       Date:  1975-09       Impact factor: 3.616

2.  Temperature-sensitive viruses and the etiology of chronic and inapparent infections.

Authors:  O T Preble; J S Youngner
Journal:  J Infect Dis       Date:  1975-04       Impact factor: 5.226

3.  Protease activation mutants of sendai virus. Activation of biological properties by specific proteases.

Authors:  A Scheid; P W Choppin
Journal:  Virology       Date:  1976-01       Impact factor: 3.616

4.  The synthesis of sendai virus polypeptides in infected cells.

Authors:  R A Lamb; B W Mahy; P W Choppin
Journal:  Virology       Date:  1976-01       Impact factor: 3.616

5.  Temperature-sensitive phenomenon of viral maturation observed in BHK cells persistently infected with HVJ.

Authors:  I Nagata; Y Kimura; Y Ito; T Tanaka
Journal:  Virology       Date:  1972-08       Impact factor: 3.616

6.  Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virus.

Authors:  A Scheid; P W Choppin
Journal:  Virology       Date:  1974-02       Impact factor: 3.616

7.  Intracellular transfer of hemadsorption type 2 virus antigen during persistent infection of HeLa cell cultures.

Authors:  T Miyamoto; Y Hinuma; N Ishida
Journal:  Virology       Date:  1965-09       Impact factor: 3.616

8.  On the study of Sendai virus hemolysis. I. Complete Sendai virus lacking in hemolytic activity.

Authors:  M Homma; K Shimizu; Y K Shimizu; N Ishida
Journal:  Virology       Date:  1976-05       Impact factor: 3.616

9.  Identification of paramyxovirus-specific haemolysis-inhibiting antibodies separate from haemagglutinating-inhibiting and neuraminidase-inhibiting antibodies. 1. Sendai virus haemolysis-inhibiting antibodies.

Authors:  C Orvell
Journal:  Acta Pathol Microbiol Scand B       Date:  1976-12

10.  Persistent infection of cells in culture by measles virus. II. Effect of measles antibody on persistently infected HeLa sublines and recovery of a HeLa clonal line persistently infected with incomplete virus.

Authors:  R Rustigian
Journal:  J Bacteriol       Date:  1966-12       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.